Skip to main content
. Author manuscript; available in PMC: 2019 Dec 13.
Published in final edited form as: Pediatr Pulmonol. 2015 Jun 18;50(10):963–969. doi: 10.1002/ppul.23237

TABLE 3—

Mean (95%CI) Differences in FEV1% Predicted at Baseline and Change in FEV1 Predicted Over Time as a Function of Baseline PG1

FEV1% predicted at baseline and as a function of PG1 and time
Male Female
Model FEV1% predicted Mean (95%CI) P-value Mean (95%CI) P-value
Model allowing FEV1% predicted to differ by constant across all times based on baseline PG1
Unadjusted Baseline PG1 < 160 98 (92, 104) NA 102 (95, 108) NA
Baseline PG1 > 160 96 (88, 104) NS2 86 (78, 95) 0.0042
Change (per year) 0.8 (0.1, 1.5) 0.033 0.3 (−0.6, 1.3) NS3
Adjusted1 Baseline PG1 < 160 93 (78, 107) NA 113 (95, 131) NA
Baseline PG1 > 160 92 (74, 110) NS2 106 (85, 127) 0.202
Change (per year) 0.6 (0.5, 1.9) 0.0013 0.3 (−0.3, 1.5) 0.203
Model allowing FEV1% predicted to differ over time as function of PG14
Adjusted1 Baseline PG1 < 160 92 (78, 106) NA 113 (91, 131) NA
Baseline PG1 > 160 94 (76, 112) NS2 106 (84, 127) 0.162
Changer for baseline < 160 1.5 (0.6, 2.3) 0.0013 0.7 (−1.2, 2.6) NS3
Change for baseline >160 0.6 (−0.8, 1.9) 0.203 1.1 (−0.5, 2.7) NS3
1

Adjusted for BMI percentile and age at study entry.

2

For the test of whether mean FEV1% predicted at baseline differed as a function of PG1.

3

For the test of whether the rate of change in FEV1% predicted changes over time.

4

Model includes interaction term for PG1 × time in study.